ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 12:06PM EDT. Market open.
| Previous close | 66.52 |
| Open | 66.96 |
| Bid | 67.32 x 100 |
| Ask | 67.57 x 100 |
| Day's range | 66.78 - 67.87 |
| 52-week range | 37.64 - 70.81 |
| Volume | |
| Avg. volume | 145,693 |
| Market cap | 1.415B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 79.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales for the full year.
- Zacks
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
- Zacks
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
© 2024 Yahoo. All rights reserved.